Characteristics of women with and without breast augmentation

JAMA

Volumn 277, Issue 20, 1997, Pages 1612-1617

  Cook, Linda S ^a   Daling, Janet R ^a,b   Voigt, Lynda F ^a,b   DeHart, M Patricia ^a   Malone, Kathleen E ^a,b   Stanford, Janet L ^c   Weiss, Noel S ^a,b   Brinton, Louise A ^d   Gammon, Marilie D ^e   Brogan, Donna ^f  

^a Fred Hutchinson Cancer Research Center   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d Critical Care Medicine Department   (United States)

^e Och Spine at New York Presbyterian Hospitals   (United States)

^f EMORY UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HAIR DYE; ORAL CONTRACEPTIVE AGENT;

ADULT; AGE; ALCOHOL CONSUMPTION; ARTICLE; BREAST AUGMENTATION; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; ORAL CONTRACEPTION; PREGNANCY TERMINATION; PRIORITY JOURNAL; SEXUAL BEHAVIOR;

EID: 0030915933     PISSN: 00987484     EISSN: None     Source Type: Journal    
DOI: 10.1001/jama.277.20.1612     Document Type: Article

References (34)

1. Bridges AJ, Conley C, Wang G, Burns DE, Vasey FB. A clinical and immunologic evaluation of women with silicone breast implants and symptoms of rheumatic disease. Ann Intern Med. 1993;118: 929-936.
2. Deapen DM, Brody GS. Augmentation mammaplasty and breast cancer: a 5-year update of the Los Angeles study. Plast Reconstr Surg. 1992;89:660-665.
3. Spiera H. Scleroderma after silicone augmentation mammoplasty. JAMA. 1988;60:236-238.
4. Giltay EJ, Moens HJB, Riley AH, Tan RG. Silicone breast prostheses and rheumatic symptoms: a retrospective follow-up study. Ann Rheum Dis. 1994;53:194-196.
5. McLaughlin JK, Fraumeni JF, Olsen J, Mellemkjaer L. Re: breast implants, cancer, and systemic sclerosis. J Natl Cancer Inst. 1994;86:1424.
6. Silverman BG, Brown SL, Bright RA, Kaczmarek RG, Arrowsmith-Lowe JB, Kessler DA. Reported complications of silicone gel breast implants: an epidemiologic review. Ann Intern Med. 1996;124: 744-756.
7. Gabriel SE, O'Fallen WM, Kurland LT, Beard CM, Woods JE, Melton LJ. Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med. 1994;330:1697-1702.
8. Bryant H, Brasher P. Breast implants and breast cancer: reanalysis of a linkage study. N Engl J Med. 1995;332:1535-1539.
9. Sanchez-Guerrero J, Colditz GA, Karlson EW, Hunter DJ, Speizer FE, Liang MH. Silicone breast implants and the risk of connective-tissue diseases and symptoms. N Engl J Med. 1995;332:1666-1670.
10. Hennekens CH, Lee I, Cook NR, et al. Self-reported breast implants and connective-tissue diseases in female health professionals. JAMA. 1996; 275:616-621.
11. Brinton LA, Malone KE, Coates RJ, et al. Breast enlargement and reduction: results from a breast cancer case-control study. Plast Reconstr Surg. 1996; 97:269-275.
12. Kessler DA. The basis of the FDA's decision on breast implants. N Engl J Med. 1992;326:1713-1715.
13. Cook RR, Delongchamp RR, Woodbury MA, Perkins LL, Harrison MC. The prevalence of women with breast implants in the United States. J Clin Epidemiol. 1995;48:519-525.
14. Angell M. Breast implants: protection or paternalism. N Engl J Med. 1992;326:1695-1696.
15. Brinton LA, Daling JR, Liff JM, et al. Oral contraceptives and breast cancer risk among young women. J Natl Cancer Inst. 1995;87:827-835.
16. Daling JR, Brinton LA, Voigt LF, et al. Risk of breast cancer among white women following induced abortion. Am J Epidemiol. 1996;144:373-380.
17. Waksberg J. Sampling methods for random digit dailing. J Am. Stat Assoc. 1978;73:40-46.
18. Brogan D. Area probability sampling versus random digit dialing (RDD) sampling in cancer epidemiology: an empirical comparison. Seminar presented to the Statistics Department; April 19,1996; Purdue University, West Lafayette, Ind.
19. White E, Malone KE, Weiss NS, Daling JR. Breast cancer among young US women in relation to oral contraceptive use. J Natl Cancer Inst. 1994; 86:505-514.
20. Stanford JL, Weiss NS, Voigt LF, Daling JR, Habel LA, Rossing MA. Combined estrogen and progestin hormone replacement therapy in relation to risk of breast cancer in middle-aged women. JAMA. 1995;274:137-142.
21. Voigt LF, Koepsell TD, Nelson JL, Dugowson CE, Daling JR. Smoking, obesity, alcohol consumption, and the risk of rheumatoid arthritis. Epidemiology. 1994;5:525-532.
22. Voigt LF, Weiss NS, Chu J, Daling JR, McKnight B, van Belle G. Progestagen supplementation of exogenous oestrogens and risk of endometrial cancer. Lancet. 1991;338:274-277.
23. Green P, Weiss NS, McKnight B, Voigt LF, Beresford S. Risk of endometrial cancer following cessation of menopausal hormone use. Cancer Causes Control. 1996;7:575-580.
24. Breslow NE, Day NE. Statistical Methods in Cancer Research: Vol I, The Analysis of CaseControl Studies. Lyon, France: International Agency for Research on Cancer; 1980.
25. Hanley JA, Lippman-Hand A. If nothing goes wrong, is everything all right? interpreting zero numerators. JAMA. 1983;249:1743-1745.
26. Sanchez-Guerrero J, Larlson EW, Colditz GA, Hunter DJ, Speizer FE, Liang MH. Hair dye use and the risk of developing systemic lupus erythematosus. Arthritis Rheum. 1996;39:657-662.
27. Freni-Titulaer LWJ, Kelley DB, Grow AG, McKinley TW, Arnett FC, Hochberg MC. Connective tissue disease in southeastern Georgia: a casecontrol study of etiological factors. Am J Epidemiol. 1989;130:404-409.
28. Petri M, Allbritton J. Hair product use in systemic lupus erythematosus. Arthritis Rheum. 1992; 35:625-629.
29. Hazes JM, van Zeben D. Oral contraception and its possible protection against rheumatoid arthritis. Ann Rheum Dis. 1991;50:72-74.
30. Koepsell T, Dugowson C, Voigt L, et al. Preliminary findings from a case-control study of the risk of rheumatoid arthritis in relation to oral contraceptive use. Br J Rheumatol. 1989;28(suppl 1): 41. Abstract.
31. Vandenbroucke JP, Valkenburg HA, Boersma JW, et al. Oral contraceptives and rheumatoid arthritis: further evidence for a preventive effect. Lancet. 1982;2:839-842.
32. Spector TD, Roman E, Silman AJ. The pill, parity, and rheumatoid arthritis. Arthritis Rheum. 1990;33:782-789.
33. Hazes JM, Dijkmans BC, Vandenbroucke JP, de Vries RR, Cats A. Reduction of the risk of rheumatoid arthritis among women who take oral contraceptives. Arthritis Rheum. 1990;33:173-179.
34. Pladevall-Vila M, Delclos GL, Varas C, Guyer H, Brugues-Tarradellas J, Anglada-Arisa A. Controversy of oral contraceptives and risk of rheumatoid arthritis: meta-analysis of conflicting studies and review of conflicting meta-analyses with special emphasis on analysis of heterogeneity. Am J Epidemiol. 1996;144:1-14.